drugset / Trial / NCT03802162
A Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-355
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the pharmacokinetics, safety and tolerability of CKD-355.
Timeline
- Start
- 2019-02-15
- Primary completion
- 2019-05-10
- Completion
- 2019-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Donepezil | Small molecule | — | — |
| Subject | Memantine | Unknown | 10 mg | — |
| Subject | Memantine | Unknown | 20 mg | — |